Rebound of COVID-19 infection in patients with chronic lymphocytic leukemia treated for SARS-CoV-2 with Nirmatrelvir/Ritonavir or Molnupiravir

Tamar Tadmor; Guy Melamed; Tal Patalon; Hilel Alapi; Lior Rokach

doi:10.1080/10428194.2023.2183732

Rebound of COVID-19 infection in patients with chronic lymphocytic leukemia treated for SARS-CoV-2 with Nirmatrelvir/Ritonavir or Molnupiravir

Tamar Tadmor, Guy Melamed, Tal Patalon, Hilel Alapi, Lior Rokach

Department of Software and Information Systems Engineering

Research output: Contribution to journal › Letter › peer-review

Original language	English
Journal	Leukemia and Lymphoma
DOIs	https://doi.org/10.1080/10428194.2023.2183732
State	Accepted/In press - 1 Jan 2023

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/10428194.2023.2183732

Cite this

@article{7d0a7dae11e044399565af9822171318,

title = "Rebound of COVID-19 infection in patients with chronic lymphocytic leukemia treated for SARS-CoV-2 with Nirmatrelvir/Ritonavir or Molnupiravir",

author = "Tamar Tadmor and Guy Melamed and Tal Patalon and Hilel Alapi and Lior Rokach",

year = "2023",

month = jan,

day = "1",

doi = "10.1080/10428194.2023.2183732",

language = "English",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

}

TY - JOUR

T1 - Rebound of COVID-19 infection in patients with chronic lymphocytic leukemia treated for SARS-CoV-2 with Nirmatrelvir/Ritonavir or Molnupiravir

AU - Tadmor, Tamar

AU - Melamed, Guy

AU - Patalon, Tal

AU - Alapi, Hilel

AU - Rokach, Lior

PY - 2023/1/1

Y1 - 2023/1/1

UR - http://www.scopus.com/inward/record.url?scp=85150617360&partnerID=8YFLogxK

U2 - 10.1080/10428194.2023.2183732

DO - 10.1080/10428194.2023.2183732

M3 - Letter

C2 - 36912366

AN - SCOPUS:85150617360

SN - 1042-8194

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

ER -

Rebound of COVID-19 infection in patients with chronic lymphocytic leukemia treated for SARS-CoV-2 with Nirmatrelvir/Ritonavir or Molnupiravir

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this